Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Azman

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Epidemiology and Infection|January 24, 2022
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infectionMd S Bhuiyan, Ben J Brintz, Alana L Whitcombe, et al.
PLOS Global Public Health|April 22, 2025
Care-seeking for diarrheal illness: A systematic review and meta-analysisKirsten E Wiens, Marissa H Miller, Daniel J Costello, et al.
Annals of Internal Medicine|March 10, 2020
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationStephen A Lauer, Kyra H Grantz, Qifang Bi, et al.
Epidemiology and Infection|November 25, 2022
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUMMd S Bhuiyan, Ben J Brintz, Alana L Whitcombe, et al.
Emerging Infectious Diseases|July 23, 2024
Spatiotemporal Modeling of Cholera, Uvira, Democratic Republic of the Congo, 2016-2020Ruwan Ratnayake, Jackie Knee, Oliver Cumming, et al.
Science (New York, N.Y.)|April 30, 2021
Household COVID-19 risk and in-person schoolingJustin Lessler, M Kate Grabowski, Kyra H Grantz, et al.
Plos One|December 17, 2021
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, KenyaEtienne Gignoux, Frida Athanassiadis, Ahmed Garat Yarrow, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Long-Term Antibody Responses to <i>Vibrio cholerae</i> Across Natural Infection, Vaccination, and Challenge: A Systematic ReviewAparna Mangadu, Christy Clutter, Kenadee Jacobson, et al.
Epidemics|May 17, 2022
Applying mixture model methods to SARS-CoV-2 serosurvey data from GenevaJudith A Bouman, Sarah Kadelka, Silvia Stringhini, et al.
Plos One|February 14, 2024
Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, KenyaEtienne Gignoux, Frida Athanassiadis, Ahmed Garat Yarrow, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Epidemiology and Infection|January 24, 2022
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infectionMd S Bhuiyan, Ben J Brintz, Alana L Whitcombe, et al.
PLOS Global Public Health|April 22, 2025
Care-seeking for diarrheal illness: A systematic review and meta-analysisKirsten E Wiens, Marissa H Miller, Daniel J Costello, et al.
Annals of Internal Medicine|March 10, 2020
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationStephen A Lauer, Kyra H Grantz, Qifang Bi, et al.
Epidemiology and Infection|November 25, 2022
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUMMd S Bhuiyan, Ben J Brintz, Alana L Whitcombe, et al.
Emerging Infectious Diseases|July 23, 2024
Spatiotemporal Modeling of Cholera, Uvira, Democratic Republic of the Congo, 2016-2020Ruwan Ratnayake, Jackie Knee, Oliver Cumming, et al.
Science (New York, N.Y.)|April 30, 2021
Household COVID-19 risk and in-person schoolingJustin Lessler, M Kate Grabowski, Kyra H Grantz, et al.
Plos One|December 17, 2021
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, KenyaEtienne Gignoux, Frida Athanassiadis, Ahmed Garat Yarrow, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Long-Term Antibody Responses to <i>Vibrio cholerae</i> Across Natural Infection, Vaccination, and Challenge: A Systematic ReviewAparna Mangadu, Christy Clutter, Kenadee Jacobson, et al.
Epidemics|May 17, 2022
Applying mixture model methods to SARS-CoV-2 serosurvey data from GenevaJudith A Bouman, Sarah Kadelka, Silvia Stringhini, et al.
Plos One|February 14, 2024
Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, KenyaEtienne Gignoux, Frida Athanassiadis, Ahmed Garat Yarrow, et al.
Pageof 21